ImpediMed Limited (IPD.AX)
AUD 0.04
(-7.69%)
AUD 0.04
(-7.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -19.03 Million AUD | 16.68% |
| 2023 | -22.84 Million AUD | -7.63% |
| 2022 | -21.22 Million AUD | 7.78% |
| 2021 | -23.01 Million AUD | 9.77% |
| 2020 | -25.51 Million AUD | 5.38% |
| 2019 | -26.96 Million AUD | 12.22% |
| 2018 | -30.71 Million AUD | 0.22% |
| 2017 | -30.78 Million AUD | -8.0% |
| 2016 | -28.49 Million AUD | -88.17% |
| 2015 | -15.14 Million AUD | -89.05% |
| 2014 | -8.01 Million AUD | 15.2% |
| 2013 | -9.44 Million AUD | 29.84% |
| 2012 | -13.46 Million AUD | 11.73% |
| 2011 | -15.25 Million AUD | -30.47% |
| 2010 | -11.69 Million AUD | 17.46% |
| 2009 | -14.16 Million AUD | -44.41% |
| 2008 | -9.8 Million AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -12.08 Million AUD | 0.0% |
| 2024 FY | -23.97 Million AUD | -4.94% |
| 2024 Q4 | 10.53 Million AUD | 0.0% |
| 2023 Q2 | -11.83 Million AUD | 0.0% |
| 2023 FY | -22.84 Million AUD | -7.63% |
| 2023 Q4 | -10.47 Million AUD | 0.0% |
| 2022 Q4 | -11.42 Million AUD | 0.0% |
| 2022 FY | -21.22 Million AUD | 7.78% |
| 2022 Q2 | -9.54 Million AUD | 0.0% |
| 2021 Q4 | -11.05 Million AUD | 0.0% |
| 2021 Q2 | -11.93 Million AUD | 0.0% |
| 2021 FY | -23.01 Million AUD | 9.77% |
| 2020 Q2 | -14.27 Million AUD | 0.0% |
| 2020 Q4 | -11.04 Million AUD | 0.0% |
| 2020 FY | -25.51 Million AUD | 5.38% |
| 2019 Q4 | -13.26 Million AUD | 0.0% |
| 2019 Q2 | -13.72 Million AUD | 0.0% |
| 2019 FY | -26.96 Million AUD | 12.22% |
| 2018 Q2 | -15.8 Million AUD | 0.0% |
| 2018 FY | -30.71 Million AUD | 0.22% |
| 2018 Q4 | -14.9 Million AUD | 0.0% |
| 2017 FY | -30.78 Million AUD | -8.0% |
| 2017 Q2 | -15.45 Million AUD | 0.0% |
| 2017 Q4 | -15.32 Million AUD | 0.0% |
| 2016 Q4 | -17.26 Million AUD | 0.0% |
| 2016 FY | -28.49 Million AUD | -88.17% |
| 2016 Q2 | -11.23 Million AUD | 0.0% |
| 2015 FY | -15.14 Million AUD | -89.05% |
| 2015 Q2 | -6.27 Million AUD | 0.0% |
| 2015 Q4 | -8.86 Million AUD | 0.0% |
| 2014 Q4 | -4.39 Million AUD | 0.0% |
| 2014 FY | -8.01 Million AUD | 15.2% |
| 2014 Q2 | -3.62 Million AUD | 0.0% |
| 2013 Q2 | -5.29 Million AUD | 0.0% |
| 2013 Q4 | -4.15 Million AUD | 0.0% |
| 2013 FY | -9.44 Million AUD | 29.84% |
| 2012 Q3 | -3.33 Million AUD | 0.0% |
| 2012 FY | -13.46 Million AUD | 11.73% |
| 2012 Q2 | -3.33 Million AUD | 11.99% |
| 2012 Q1 | -3.79 Million AUD | 0.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2011 Q1 | -2.9 Million AUD | 0.0% |
| 2011 Q2 | -3.79 Million AUD | -30.61% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 FY | -15.25 Million AUD | -30.47% |
| 2011 Q3 | -3.79 Million AUD | 0.0% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -2.9 Million AUD | 0.0% |
| 2010 FY | -11.69 Million AUD | 17.46% |
| 2010 Q2 | -2.9 Million AUD | 17.96% |
| 2010 Q1 | -3.54 Million AUD | 0.0% |
| 2009 Q3 | -3.54 Million AUD | 0.0% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 Q2 | -3.54 Million AUD | -44.41% |
| 2009 Q1 | -2.45 Million AUD | 0.0% |
| 2009 FY | -14.16 Million AUD | -44.41% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q2 | -2.45 Million AUD | 0.0% |
| 2008 Q1 | - AUD | 0.0% |
| 2008 FY | -9.8 Million AUD | 0.0% |
| 2008 Q3 | -2.45 Million AUD | 0.0% |
| 2007 Q3 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 31.932% |
| Adherium Limited | -11.98 Million AUD | -58.828% |
| Aroa Biosurgery Limited | -9.78 Million AUD | -94.489% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -336.458% |
| Anteris Technologies Ltd | -66.63 Million AUD | 71.431% |
| Control Bionics Limited | -5.92 Million AUD | -221.052% |
| CardieX Limited | -4.63 Million AUD | -310.815% |
| Compumedics Limited | -269 Thousand AUD | -6976.58% |
| Cochlear Limited | 521.5 Million AUD | 103.65% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -295.433% |
| Cyclopharm Limited | -9.22 Million AUD | -106.36% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -1079.131% |
| Nova Eye Medical Limited | -3.79 Million AUD | -401.343% |
| HeraMED Limited | -6.42 Million AUD | -196.142% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | -8.311% |
| InhaleRx Limited | -1.38 Million AUD | -1272.966% |
| LBT Innovations Limited | -4.74 Million AUD | -301.603% |
| Micro-X Limited | -13.02 Million AUD | -46.127% |
| Neurotech International Limited | -5.58 Million AUD | -240.854% |
| OncoSil Medical Limited | -11.98 Million AUD | -58.842% |
| PolyNovo Limited | 1.16 Million AUD | 1736.801% |
| Respiri Limited | -7 Million AUD | -171.935% |
| SomnoMed Limited | -3.84 Million AUD | -395.562% |
| Universal Biosensors, Inc. | -16.68 Million AUD | -14.123% |
| Uscom Limited | -2.4 Million AUD | -691.732% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | -225.172% |